NASDAQ$CORZ
Core Scientific · Q2 2024 earnings
Q2 2024 earnings ·
Briefing
CORZ Q2 2024 — $7.9M revenue, 12.00 EPS
These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions, known or unknown, that could cause actual results to vary materially . Core Scientific reported Q2 2024 results. Diluted EPS came in at $12.00. Headline numbers extracted from the Form 10-Q press release; narrative is light because this row was processed without an LLM call.
- Revenue: $7.9M.
- Diluted EPS: $12.00.
- Operating income: $7K.
- Gross profit: $39K.
Headline financials
Revenue & EPS history
Core Scientific · Revenue · Quarterly
$141M
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 8 quarterly earnings reports · overlaid with Q2 2024
+3.9%
Avg return
Earnings day
+6.3%
Avg return
5 days after
+20.6%
Avg return
30 days after
75%
6 / 8 earnings
Positive
+11.0%
Q1 2026
Best reaction
-7.2%
Q4 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +11.0% | +3.4% | +16.5% | |
| Q4 2025 | -7.2% | -9.9% | -1.6% | |
| Q3 2025 | +0.0% | +7.2% | -18.6% | |
| Q1 2025 | +6.2% | +15.1% | +37.0% | |
| Q4 2024 | +6.9% | -4.3% | -25.3% | |
| Q3 2024 | +10.1% | +34.2% | +30.5% | |
| Q2 2024 | +1.1% | -2.5% | -4.0% | |
| Q1 2024 | +3.0% | +7.5% | +130.2% | |
| Q3 2023 | — | — | — | |
| Q2 2023 | — | — | — | |
| Q1 2023 | — | — | — | |
| Q3 2022 | — | — | — | |
| Q2 2022 | — | — | — | |
| Q1 2022 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro